Revolutionizing Alzheimer’s drug discovery using bio-photonics and AI

Clinical trials need help!

Failure of One-Drug-Fits-All

Several potential effective drugs have been abandoned by the pharmaceutical companies due to problems related to clinical trials.

Unscalable

Per year, just the top four pharmaceutical companies spend over 400M€ in screening for Alzheimer’s clinical trials.

Patient Invasive

90% of initially enrolled patients drop out of the clinical trials due to issues with invasiveness and inconvenience of screening procedures (PET and lumbar puncture).

Inefficient

From the patients that are screened 80% are excluded for not fitting the trial, after being subjected to various invasive, unconfortable, risky procedures.

About us

How can we help?

Stratifying and screening patients in Alzheimer’s clinical trials in the right way.
• Inexpensive: 40% less cost
• Scalable: 70% less time
• Patient-friendly: Non-invasive

Team

Luís Valente

Luís Valente

CEO

Award-winning business manager and engineer, founded first company at 18

LinkedIn

Joana S. Paiva

Joana S. Paiva

CTO

Inventor, scientist, Professor in Physics and Biomedical and Physics engineer

LinkedIn

Paula Sampaio

Paula Sampaio

CSO

Senior scientist, Professor, Innovation in Healthcare envangelist

LinkedIn

Mehak Mumtaz

Mehak Mumtaz

COO

Personalized medicine expert and PhD turned strategic consultant to C-Level leaders

LinkedIn

Mentors & Advisors

Jorge Fernández García

Jorge Fernández García

Mentor & Advisor

EIT Health Director of Innovation, more than 18 years of experience in healthcare and life sciences

LinkedIn

João Paulo Cunha

João Paulo Cunha

Mentor & Advisor

Innovator, inventor, passionate Professor of Bioengineering. Proud founder/mentor of 6 startups with tech from his lab, and counting

LinkedIn

Pedro Jorge

Pedro Jorge

Advisor

Renowned scientist in Photonics with vast technology transfer experience in optical fibre sensing technology, coordinator of more than 18 projects

LinkedIn

Leveraging machine learning to drastically reduce the cost and time of drug discovery.

Awards

News

Coverage of iLoF by the Portuguese press

Altice Innovation Award media coverage

iLoF at the EIT Health Biobanks and Health Registers event at BioClinicum/Karolinska University Hospital, Stockholm

Partners

GET IN TOUCH

+351 220 426 664

info@ilof.tech

Medical Research Center – Faculty of Medicine of University of Porto – Alameda Prof. Hernâni Monteiro Porto – Portugal